About Thomas Hermann
Form D filings for Syrna Therapeutics in 2023 list Thomas Hermann as director.
Thomas Hermann first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Thomas Hermann in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Thomas Hermann works with at each company, as listed on that company's latest Form D.
Syrna Therapeutics, Inc. · Form D, Aug 10, 2023